James R Tobin Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 1 week, 1 day ago
James R Tobin has an estimated net worth of at least $15.3 million*, as of Dec. 18, 2024. They own 19,925 shares of TMDX stock. They have sold 240,475 shares of TMDX stock since 2021, for an estimated $14.0 million.
James R Tobin $TMDX SEC Form 4 Insider Trading
James R Tobin has filed a total of 18 insider trades in $TMDX since 2021. Their most recent trade was a sale of 12,664 shares, made on Aug 08, 2024. Their largest trade was a sale of 48,516 shares, made on May 04, 2022. We estimate that they now own 19,925 shares of $TMDX, worth an estimated $1.3 million.
Insider Trading at $TMDX
There have been a total of 315 insider trades reported at $TMDX since 2021, with 102,500 shares purchased and 1.3 million shares sold. The most active insider traders in $TMDX stock have been Tamer I Khayal, Waleed H Hassanein, and John F Carey. The most recent trade was a sale of 1,084 shares reported by Tamer I Khayal (Chief Commercial Officer), made on Dec 02, 2024.
History of Insider Stock Trades by James R Tobin
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
TMDX
|
Sale | 12,664 | Aug 08, 2024 | Aug. 9, 2024, 4:30 p.m. |
|
TMDX
|
Sale | 7,336 | Aug 08, 2024 | Aug. 9, 2024, 4:30 p.m. |
|
TMDX
|
Sale | 5,130 | May 03, 2024 | May 7, 2024, 4:30 p.m. |
|
TMDX
|
Sale | 6,895 | May 03, 2024 | May 7, 2024, 4:30 p.m. |
|
TMDX
|
Sale | 1,704 | May 01, 2024 | May 3, 2024, 4:32 p.m. |
|
TMDX
|
Sale | 11,236 | May 01, 2024 | May 3, 2024, 4:32 p.m. |
|
TMDX
|
Sale | 2,000 | May 01, 2024 | May 3, 2024, 4:32 p.m. |
|
TMDX
|
Sale | 100 | May 01, 2024 | May 3, 2024, 4:32 p.m. |
|
TMDX
|
Sale | 2,900 | Mar 01, 2024 | March 5, 2024, 7:16 p.m. |
|
TMDX
|
Sale | 200 | Mar 01, 2024 | March 5, 2024, 7:16 p.m. |
|
TMDX
|
Sale | 4,234 | Mar 01, 2024 | March 5, 2024, 7:16 p.m. |
|
TMDX
|
Sale | 5,746 | Mar 01, 2024 | March 5, 2024, 7:16 p.m. |
|
TMDX
|
Sale | 300 | Mar 01, 2024 | March 5, 2024, 7:16 p.m. |
|
TMDX
|
Sale | 10,000 | Nov 28, 2023 | Nov. 29, 2023, 5:38 p.m. |
|
TMDX
|
Sale | 10,000 | Feb 23, 2023 | Feb. 27, 2023, 9 p.m. |
|
TMDX
|
Sale | 48,515 | Jul 29, 2022 | Aug. 1, 2022, 8:30 p.m. |
|
TMDX
|
Sale | 48,515 | Jul 05, 2022 | July 6, 2022, 6:17 p.m. |
|
TMDX
|
Sale | 48,516 | May 04, 2022 | May 6, 2022, 4:05 p.m. |
GMED
|
Sale | 4,484 | Mar 08, 2022 | March 10, 2022, 9:07 p.m. |
|
GMED
|
Sale | 10,000 | Mar 10, 2022 | March 10, 2022, 9:07 p.m. |
$TMDX Executives and Stock Owners with Insider Trades
-
Tamer I Khayal, Chief Commercial Officer
-
Waleed H Hassanein, President & CEO
-
John F Carey, VP of Operations
-
Stephen Gordon, Chief Financial Officer
-
Miriam Provost, VP, Global Regulatory Affairs
-
Laura Damme, VP, Clinical Affairs
-
Anil P. Ranganath, See remarks
-
Nicholas Corcoran, See Remarks
-
Miriam Provost, VP of US Regulatory & FDA Rel.
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.